{"nct_id":"NCT01160211","title":"A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer","status":"COMPLETED","status_verified_date":"2025-03","start_date":"2011-05-05","start_date_type":"ACTUAL","primary_completion_date":"2016-03-11","primary_completion_date_type":"ACTUAL","completion_date":"2022-06-06","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}